1 / 13

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland. Józef Woźny- President. Pharmaceutical Sector in Poland.

nika
Download Presentation

INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND T.U. Federation of Chemical, Glass and CeramicIndustriesin Poland. Józef Woźny- President

  2. Pharmaceutical Sector in Poland • National Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses. It also has a great importance for the economy of providing 55% of the medicines sold in Poland. • Polish pharmaceutical industry is one of the largest generic medicines producer in Europe. It provides public access to medicines of good qualitywith benefit price(more than 50% of the packages in the market comes from domestic plants).

  3. Average prices of generic and innovative medicines in Europe(net producer prices, EUR)

  4. Structure of the Polish pharmaceutical market broken down by original and generic medicines in 2011 (net producer prices). Valuable Quantitative Oryginal Generic

  5. Pharmaceutical Sector in Poland: Only one plant-PolfaTarchomin remains in the hands of the Treasury.

  6. Pharmaceutical Sector in Poland Domestic pharmaceutical companies more than 60% of the profit is investing. Theseinvestments have allowed companies such as for: • Process to complete implementation of Quality Management Systems, • implementationof Good Manufacturing Practice (GMP), the adjustment of medicines documents with European Union requirements, • employment restructuring, development cooperation programs in science, • increase in the number of patents, the development of biotechnology, • the adaptation of production to high standards of environmental protection. Domestic pharmaceutical companies spend on research and development, 13% of the profits, where the average for the processing industry in Poland is 3.5%.

  7. Pharmaceutical Sector in Poland The export of medicines toEU countries are 75.6%. Among the countries to which exported the Polish medicine complex, the majority were: Germany (15.5% of Polish exports) and the United Kingdom, France and Russia (about 9% of Polish foreign sales).

  8. Amount of workers in pharmaceutical industry in the years 2006-2010 (in the person of the end of the year) Domestic pharmaceutical industry employs approx. 23 000 peoples.

  9. The average monthly salary per employee in manufacturing andpharmaceutical industry in the years 2006-2010. Salary in the manufacturing industry was 3 250.00 PLN in the pharmaceutical industry 5 319.00 PLN.

  10. Pharmaceutical Sector in Poland Trade Union membership in the pharmaceutical industry is in the range of 30-35%. In the factories functioning Works Collective LabourAgreements. Where are the European Works Council representatives of Polish pharmaceutical companies are authorized. Works Council functioning of each plant. Multi-establishment collective agreement is not signed, has not given its consent Employers Association of Pharmaceutical Industries.

  11. Activities in the area of corporate social responsibility Charitable activities Sponsoring of sport and cultural news Organized of seminars and science conferences Information actions for the patients Investments in environmental Free diagnostics for patients Other Companies don’t take activities on this field.

  12. Impacts that could affect most business development in Polish pharmaceutical sector. The introduction a new products in market The overall increase in wealth of the society The access to reimbursement The access to investment funds Improving the law system The marketing actions Improving quality of products Output from outside the polish market Increasing health consciousness of Poles Increasing of amount of sales representatives

  13. Pharmaceutical Sector in Poland THANK YOU FOR ATTENTION! Presentation preparedon the basis of the documentation: 1. PolishEmployersAssociation in the Pharmaceutical Industry 2. Department of Economic Information- Invest In Poland 3. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland

More Related